Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000036279 | SCV000059931 | likely benign | not specified | 2013-12-26 | criteria provided, single submitter | clinical testing | 25-4C>T in intron 2 of TNNI3: This variant is not expected to have clinical sign ificance because it does not affect the splice consensus sequence. It has been i dentified in 0.25% (10/4014) of African American chromosomes from a broad popula tion by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/EVS) 2 5-4C>T in intron 2 of TNNI3 (allele frequency = 0.25%; 10/4014) |
Gene |
RCV000036279 | SCV000514918 | benign | not specified | 2015-05-12 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Invitae | RCV000462385 | SCV000562159 | benign | Hypertrophic cardiomyopathy | 2024-01-28 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000620983 | SCV000737185 | likely benign | Cardiovascular phenotype | 2019-03-04 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
CHEO Genetics Diagnostic Laboratory, |
RCV000769533 | SCV000900928 | benign | Cardiomyopathy | 2018-04-30 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000769533 | SCV001344877 | benign | Cardiomyopathy | 2018-12-13 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004549439 | SCV004758871 | likely benign | TNNI3-related disorder | 2019-12-12 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Clinical Genetics, |
RCV000036279 | SCV001924643 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV001701726 | SCV001931029 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001701726 | SCV001964087 | likely benign | not provided | no assertion criteria provided | clinical testing |